Prof. Saleh Abu Lafi is specialized in the separation and identification of new active ingredients from natural products. He received his bachelor’s and master’s degree from Yarmouk University, Jordan in 1987. In 1994, he received his doctorate from the School of Pharmacy, The Hebrew University of Jerusalem and spent three years as a visiting associate at the United States-Food and Drug Administration (FDA) until 1997.
His research interests are in the separation and identification of new active ingredients from medicinal plant materials using advanced instruments such as LCMS, LC-MSMS, NMR, HPLC-PDA, HS-SPME-GCMS. He is also interested in the development of new methods related to the separation and analysis of medicines according to FDA and ICH norms. Another field of interest is chiral and preparative (scaling up) separation of drugs. During his career, he published over 75 peer reviewed articles.
Selected 5 publications from 2018:
1. A New Approach for Indexing Honey for Its Heath/Medicinal Benefits: Visualization of the Concept by Indexing Based on Antioxidant and Antibacterial Activities, Medicines, 5, 135; doi:10.3390/medicines5040135, 2018.
2. Sesamin from Cuscuta palaestina natural plant extracts: Directions for new prospective applications, PLOS ONE, https://doi.org/10.1371/journal.pone.0195707, 2018.
3. Anticancer activity and phytochemical composition of wild Gundelia tournefortii, Oncology Letters, Pages: 713-717 DOI: 10.3892/ol.2018.9602, 2018.
4. Pure isolates and preparative HPLC fractions or crude extract of Inula viscosa: Effect on β-hematin inhibition in vitro, Pharm Pharmacol Int J, 6(1): 00145, 2018.
5. HPLC separation of phenolic phytochemicals from grape peels and seeds water extracts and their in-vitro antimalarial activities, Pharm Pharmacol Int J., 6(4):210-216, 2018.